为糖尿病个性化医疗绘制新图景
本文综述指出,当前个性化(或精准)医疗在罕见病和癌症中已显现临床获益,但对2型糖尿病等复杂疾病的管理影响仍有限,可能源于基于罕见高影响遗传和环境暴露的疾病架构模型不适用。作者提出以分子分类学为中心的「调色板」模型,聚焦个体在主要病理生理过程中的位置,并预期许多糖尿病患者存在影响多个过程的并行缺陷。
要点
- 当前个性化医疗对2型糖尿病等复杂疾病的管理影响仍有限。
- 作者提出以分子分类学为中心的「调色板」模型。
- 模型预期许多糖尿病患者存在影响多个病理生理过程的并行缺陷。
核心结论
- 作者提出「调色板」模型,以分子分类学为中心,聚焦个体在主要病理生理过程中的位置。
研究设计与样本
- 本文为综述,未报告检索范围。
主要发现
- 个性化医疗在罕见病和癌症中已显现临床获益,但对2型糖尿病等复杂疾病的管理影响仍有限。
- 作者认为这可能反映当前依赖的疾病架构模型基于罕见、高影响的遗传和环境暴露,与对2型糖尿病的新认识不匹配。
- 模型预期许多糖尿病患者存在影响多个病理生理过程的多个并行缺陷。
临床怎么用
- 作者认为研究应至少在初期聚焦于识别和表征代谢轨迹主要受限于一组有限过程扰动的个体。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The current focus on delivery of personalised (or precision) medicine reflects the expectation that developments in genomics, imaging and other domains will extend our diagnostic and prognostic capabilities, and enable more effective targeting of current and future preventative and therapeutic options. The clinical benefits of this approach are already being realised in rare diseases and cancer but the impact on management of complex diseases, such as type 2 diabetes, remains limited. This may reflect reliance on inappropriate models of disease architecture, based around rare, high-impact genetic and environmental exposures that are poorly suited to our emerging understanding of type 2 diabetes. This review proposes an alternative 'palette' model, centred on a molecular taxonomy that focuses on positioning an individual with respect to the major pathophysiological processes that contribute to diabetes risk and progression. This model anticipates that many individuals with diabetes will have multiple parallel defects that affect several of these processes. One corollary of this model is that research efforts should, at least initially, be targeted towards identifying and characterising individuals whose adverse metabolic trajectory is dominated by perturbation in a restricted set of processes.
引用
- McCarthy MI. Painting a new picture of personalised medicine for diabetes. Diabetologia. 2017. PMID: 28175964. doi:10.1007/s00125-017-4210-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。